The third dopamine receptor (D3) as a novel target for antipsychotics.
about
Blockade of mesolimbic dopamine D3 receptors inhibits stress-induced reinstatement of cocaine-seeking in ratsFurther evidence of no association between Ser9Gly polymorphism of dopamine D3 receptor gene and schizophreniaA targeted mutation of the D3 dopamine receptor gene is associated with hyperactivity in miceA receptor-based model for dopamine-induced fMRI signal.Concentration of receptor and ligand revisited in a modified receptor binding protocol for high-affinity radioligands: [3H]Spiperone binding to D2 and D3 dopamine receptorsCocaine enhancement of long-term potentiation in the CA1 region of rat hippocampus: lamina-specific mechanisms of actionRegulation of dopamine D3 receptors by protein-protein interactionsDopamine D1 and D3 receptors mediate reconsolidation of cocaine memories in mouse models of drug self-administrationAcute administration of SB-277011A, NGB 2904, or BP 897 inhibits cocaine cue-induced reinstatement of drug-seeking behavior in rats: role of dopamine D3 receptors.The D3 dopamine receptor and substance dependence.Activation of dopamine D3 receptors inhibits reward-related learning induced by cocaine.Understanding antipsychotic "atypicality": a clinical and pharmacological moving targetCocaine self-administration leads to alterations in temporal responses to cocaine challenge in limbic and motor circuitry.Behavioral sensitization, alternative splicing, and d3 dopamine receptor-mediated inhibitory function.Risperidone pretreatment prevents elevated locomotor activity following neonatal hippocampal lesions.Autoradiographic localization of dopamine D2-like receptors in the rat adrenal gland.PG01037, a novel dopamine D3 receptor antagonist, inhibits the effects of methamphetamine in ratsDopaminergic response to graded dopamine concentration elicited by four amphetamine doses.Dopamine agonists early monotherapy for the delay of development of levodopa-induced dyskinesias.YQA14: a novel dopamine D3 receptor antagonist that inhibits cocaine self-administration in rats and mice, but not in D3 receptor-knockout mice.Role of the nucleus accumbens and the striatum in the production of turning behaviour in intact rats.Mapping of dopamine D3 receptor binding site by pharmacological characterization of mutants expressed in CHO cells with the Semliki Forest virus system.Coupling of D2 and D3 dopamine receptors to G-proteins.Stable expression of human D3 dopamine receptors in GH4C1 pituitary cells.Activity-dependent modulation of limbic dopamine D3 receptors by CaMKII7-OH-DPAT and PD 128907 selectively activate the D3 dopamine receptor in a novel environment.Altered behavioral response to dopamine D3 receptor agonists 7-OH-DPAT and PD 128907 following repetitive amphetamine administration.The novel dopamine D3 receptor antagonist NGB 2904 inhibits cocaine's rewarding effects and cocaine-induced reinstatement of drug-seeking behavior in rats.Lack of association between schizophrenia and alleles in the dopamine D3 receptor gene.
P2860
Q28256337-A0237224-2941-48EF-9A84-5569DC74B3CEQ28303670-2605F6A2-999B-423C-A5E2-6B5B0958C197Q28506099-4136A23D-BB2D-46C8-87BB-AD40C1162232Q30434854-A5251E75-6AC7-4C50-AD14-1975F130D167Q33759179-22A2BC16-ED85-4BBC-9506-DCF809A6E22BQ33927928-5029A192-6E81-4DE3-99F7-5A9FA72EC3D9Q34193136-FED072E0-8771-4D02-B584-58AE6E5580DCQ34231896-212821A9-807C-417D-830B-AFFA5F3CE0D9Q34414507-1CE7721C-3205-43F2-AF09-17D9A2137B5AQ34420270-6445B683-E061-4508-A9D3-E9B68E3B8282Q34579537-D10DCD29-6968-448A-80E3-1868BE883D3CQ35200831-A86F347A-86DE-4565-8EF6-2F08926924EAQ35211775-B4F86E12-E946-4515-AFBF-0C4342270A78Q35669960-51236A18-023A-4A18-92B5-05196CBCDF1DQ35742020-234DB550-C4A6-4F66-89C6-12A493908F4BQ36709425-AEF4A12E-FC4D-48AA-8F94-FB2AFD28F358Q37060818-D2923A51-A368-483D-AF78-79BC90584B97Q37377944-E86D89CD-B92A-469C-B617-9B58A9662247Q38314257-AE933C1D-3015-4A17-8C82-0B601984B7D7Q38335806-531DD52E-185D-4A26-A76D-3F4505498E62Q40494298-EEAB44FF-8601-438E-885B-16E5CAF5B8B8Q41028386-AC6E4774-FBEE-4F77-8F4F-28E942559331Q41578849-D9E0AB41-C551-4DA4-8D0C-879494D59185Q41594608-10581D34-6B97-4911-BF7A-D67A93820327Q41851301-834BDA3B-0325-4EC8-9F3D-53D42A009C5BQ44259230-5BAFF041-CEB1-4919-BBBE-87671C821E7FQ44407119-842BD45C-6731-4D73-988C-0ABA26C6D0B5Q46736593-4E7571EB-AD4B-4134-B81C-61E185D1A50CQ48286860-82C532C3-936F-4E2B-9357-A45BB8413DAC
P2860
The third dopamine receptor (D3) as a novel target for antipsychotics.
description
1992 nî lūn-bûn
@nan
1992 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
1992 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
1992年の論文
@ja
1992年論文
@yue
1992年論文
@zh-hant
1992年論文
@zh-hk
1992年論文
@zh-mo
1992年論文
@zh-tw
1992年论文
@wuu
name
The third dopamine receptor (D3) as a novel target for antipsychotics.
@ast
The third dopamine receptor (D3) as a novel target for antipsychotics.
@en
type
label
The third dopamine receptor (D3) as a novel target for antipsychotics.
@ast
The third dopamine receptor (D3) as a novel target for antipsychotics.
@en
prefLabel
The third dopamine receptor (D3) as a novel target for antipsychotics.
@ast
The third dopamine receptor (D3) as a novel target for antipsychotics.
@en
P2093
P1476
The third dopamine receptor (D3) as a novel target for antipsychotics.
@en
P2093
Bouthenet ML
Martres MP
Schwartz JC
Sokoloff P
P304
P356
10.1016/0006-2952(92)90227-A
P407
P577
1992-02-01T00:00:00Z